An Arizona Transplant Family is Celebrating National Minority Donor Awareness Week

Yuma, Arizona - August 1st - 7th is recognized as National Minority Donor Awareness Week, which was created in 1998 to increase our nation’s consciousness of the need for more organ and tissue donors -- especially among multicultural communities. National Minority Donor Awareness Week honors communities of color who have been donors, and encourages others to register as donors. It is about empowering multicultural communities to save and heal lives by registering as organ and tissue donors.

American Diabetes Association® Applauds the Insulin Price Reduction Act

Washington, DC - The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States Senate. The ADA thanks Senate Diabetes Caucus Co-Chairs Senator Jeanne Shaheen (D-NH) and Senator Susan Collins (R-ME) as well as Senator Tom Carper (D-DE) and Senator Kevin Cramer (R-ND) for their leadership in introducing this legislation, which will lower the cost of insulin for many Americans who rely on insulin to stay alive.

NIH awards contract for acute flaccid myelitis natural history study

Washington, DC - The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded the University of Alabama at Birmingham (UAB) approximately $10 million over five years to study acute flaccid myelitis (AFM), a rare but serious condition which causes muscle weakness and paralysis.

Legislation would expand access to cardiac and pulmonary rehabilitation programs

Washington, DC - Bipartisan legislation introduced in the U.S. House of Representatives would expand patient access to critical cardiac and pulmonary rehabilitation programs in Medicare. The Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 (H.R. 3911) was introduced by Representatives John Lewis (D-GA) and Adrian Smith (R-NE).

Risk of neural tube defects slightly higher for babies of women on HIV therapy containing dolutegravir

Washington, DC - Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.